Could Revolutionary Gene-Editing Technology End Cancer?
Jennifer Doudna, faculty biochemist in Molecular Biophysics & Integrated Bioimaging, and her work on the CRISPR/Cas 9 gene editing system, have been highlighted recently in both The New Yorker Magazine and on CBS This Morning. The coverage discusses the benefits and perils of this technology, which is the topic of an international meeting being held currently at the National Academy of Sciences in Washington, DC.